March 13th, 2007
A team of researchers from the University of Michigan, University of Pennsylvania, and universities in Greece and Italy have been able ton identify biomarkers unique the cells of blood vessels running through ovarian tumors.
According to study author Ronald Buckanovich, M.D., Ph.D., assistant professor of internal medicine and obstetrics and gynecology at the University of Michigan […]
By Gloria Gamat -- 1 comment
March 13th, 2007
The Cancer Treatment Centers of America is launching a new cancer vaccine therapy that will be offered by the CTCA to chemo-resistant ovarian cancers and to be developed by AVAX Technologies, Inc.
Ovarian cancer is one of the hardest to detect in early stages, a complex cancer that is often resistant to chemotherapy.
The breakthrough treatment method […]
By Gloria Gamat -- 0 comments
January 14th, 2007
A compound from specially grown soy beans – known as glyceollin – has been found over time to stop further growth of estrogen-stimulated breast and ovarian tumors in mice.
A significant finding according to Tulane cancer researcher Matthew Burow because of the lack of effective therapies available to women with advanced breast or ovarian cancer and […]
By Gloria Gamat -- 0 comments
December 12th, 2006
Welcome to today’s Cancer Commentary round-up! FYI, if you’re interested in learning more about the genetics of cancer, you might find these posts of mine at Genetics and Health worth a look.
To pinpoint [pancreatic] cancer, look at the genes - Mutation detected in the palladin gene
Cancer Society plans $25m residence in Jamaica […]
By Hsien-Hsien Lei, PhD -- 0 comments
September 3rd, 2006
Obesity in women is more likely to affect how she’ll survive ovarian cancer if she’s diagnosed with one.
That’s what the new study from Cedars-Sinai Medical Center found and reported in the August 28 online edition of American Cancer Society’s journal, Cancer: that obesity affected survival rates, shortened the length of time to recurrence of the […]
By Gloria Gamat -- 0 comments
August 23rd, 2006
Researchers at the University of Texas M. D. Anderson Cancer Center found a molecular “off” switch contained in a tiny sphere that is able to penetrate deeply into ovarian cancer cells, stifling a troublesome protein and drastically reducing the size of tumors.
The “tiny sphere” demonstrates a potent delivery system for short interfering RNA (siRNA) to […]
By Gloria Gamat -- 0 comments
August 18th, 2006
While nanotechnology is revolutionizing the world, its biggest impact in the future would be in the healthcare industry.
In a collaboration of Rush University Medical Center with Argonne National Laboratory and the Illinois Institute of Technology, nanotechnology is being utilized in searching for new ways to diagnose and treat ovarian cancer.
“While the mortality rates of many […]
By Gloria Gamat -- 0 comments
August 7th, 2006
Myriad Genetics, Inc. (Nasdaq: MYGN), maker of molecular diagnostic products, has introduced into the market its BRACAnalysis® Rearrangement Test, a new molecular diagnostic test added in the BRACAnalysis family of products.
This additional test detects rare, large rearrangements of the DNA in the BRCA1 and BRCA2 genes and will be performed for women with exceptionally high […]
By Gloria Gamat -- 0 comments
June 12th, 2006
In a mouse model of ovarian cancer, researchers at the University Of Pittsburgh School Of Medicine have used gene therapy to either completely abolish or significantly inhibit tumor progression.
These findings, the researchers believe, may significantly improve the prognosis for ovarian cancer patients. The gene therapy involved treatment with a genetically engineered vaccinia virus containing a […]
By Gloria Gamat -- 1 comment
Recent Comments